In addition, in pancreatic tumors, ovarian cancer, and nasopharyngeal carcinoma, blocking the ubiquitination of the cGAS-STING pathway may represent a novel therapeutic approach to inhibit anti-tumor immunity (39, 70, 74). Here, STING1 is linked to ovarian cancer.